These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 9687423)

  • 1. Long-term therapy with the guanine nucleoside analog penciclovir controls chronic duck hepatitis B virus infection in vivo.
    Lin E; Luscombe C; Colledge D; Wang YY; Locarnini S
    Antimicrob Agents Chemother; 1998 Aug; 42(8):2132-7. PubMed ID: 9687423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The guanine nucleoside analog penciclovir is active against chronic duck hepatitis B virus infection in vivo.
    Lin E; Luscombe C; Wang YY; Shaw T; Locarnini S
    Antimicrob Agents Chemother; 1996 Feb; 40(2):413-18. PubMed ID: 8834889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of nucleoside analogue therapy on duck hepatitis B viral replication in hepatocytes and bile duct epithelial cells in vivo.
    Nicoll A; Locarnini S; Chou ST; Smallwood R; Angus P
    J Gastroenterol Hepatol; 2000 Mar; 15(3):304-10. PubMed ID: 10764033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiviral activities of penciclovir and famciclovir on duck hepatitis B virus in vitro and in vivo.
    Offensperger WB; Offensperger S; Keppler-Hafkemeyer A; Hafkemeyer P; Blum HE
    Antivir Ther; 1996 Aug; 1(3):141-6. PubMed ID: 11322247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro antiviral activity of penciclovir, a novel purine nucleoside, against duck hepatitis B virus.
    Shaw T; Amor P; Civitico G; Boyd M; Locarnini S
    Antimicrob Agents Chemother; 1994 Apr; 38(4):719-23. PubMed ID: 8031035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiviral therapy with entecavir combined with post-exposure "prime-boost" vaccination eliminates duck hepatitis B virus-infected hepatocytes and prevents the development of persistent infection.
    Miller DS; Boyle D; Feng F; Reaiche GY; Kotlarski I; Colonno R; Jilbert AR
    Virology; 2008 Apr; 373(2):329-41. PubMed ID: 18206204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Experimental study on the effect of combination therapy with lamivudine and famciclovir against duck hepatitis B virus in vivo].
    Chen Y; Guo S; Qi Z; Huang A
    Zhonghua Gan Zang Bing Za Zhi; 2001 Aug; 9(4):209-11. PubMed ID: 11602049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The SATE pronucleotide approach applied to acyclovir: part II. Effects of bis(SATE)phosphotriester derivatives of acyclovir on duck hepatitis B virus replication in vitro and in vivo.
    Hantz O; Périgaud C; Borel C; Jamard C; Zoulim F; Trépo C; Imbach JL; Gosselin G
    Antiviral Res; 1999 Jan; 40(3):179-87. PubMed ID: 10027652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decrease of wild-type and precore mutant duck hepatitis B virus replication during lamivudine treatment in white Pekin ducks infected with the viruses.
    Tomita T; Yokosuka O; Tagawa M; Saisho H; Tamura S; Fukuda I; Omata M
    J Hepatol; 2000 May; 32(5):850-8. PubMed ID: 10845674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral famciclovir against duck hepatitis B virus replication in hepatic and nonhepatic tissues of ducklings infected in ovo.
    Tsiquaye KN; Slomka MJ; Maung M
    J Med Virol; 1994 Mar; 42(3):306-10. PubMed ID: 8006644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations in intrahepatic expression of duck hepatitis B viral markers with ganciclovir chemotherapy.
    Luscombe C; Pedersen J; Bowden S; Locarnini S
    Liver; 1994 Aug; 14(4):182-92. PubMed ID: 7968278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of antiviral treatment with entecavir on age- and dose-related outcomes of duck hepatitis B virus infection.
    Foster WK; Miller DS; Scougall CA; Kotlarski I; Colonno RJ; Jilbert AR
    J Virol; 2005 May; 79(9):5819-32. PubMed ID: 15827196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence that hepatocyte turnover is required for rapid clearance of duck hepatitis B virus during antiviral therapy of chronically infected ducks.
    Fourel I; Cullen JM; Saputelli J; Aldrich CE; Schaffer P; Averett DR; Pugh J; Mason WS
    J Virol; 1994 Dec; 68(12):8321-30. PubMed ID: 7966625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of alcohol extract of Acanthus ilicifolius L. on anti-duck hepatitis B virus and protection of liver.
    Wei PH; Wu SZ; Mu XM; Xu B; Su QJ; Wei JL; Yang Y; Qin B; Xie ZC
    J Ethnopharmacol; 2015 Feb; 160():1-5. PubMed ID: 25446633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the antiviral effects of 2' carbodeoxyguanosine in ducks chronically infected with duck hepatitis B virus.
    Mason WS; Cullen J; Saputelli J; Wu TT; Liu C; London WT; Lustbader E; Schaffer P; O'Connell AP; Fourel I
    Hepatology; 1994 Feb; 19(2):398-411. PubMed ID: 8294097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the antiviral effect of 2',3'-dideoxy-2', 3'-didehydro-beta-L-5-fluorocytidine in the duck hepatitis B virus infection model.
    Le Guerhier F; Pichoud C; Guerret S; Chevallier M; Jamard C; Hantz O; Li XY; Chen SH; King I; Trépo C; Cheng YC; Zoulim F
    Antimicrob Agents Chemother; 2000 Jan; 44(1):111-22. PubMed ID: 10602731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of anti-hepadnavirus activity of Phyllanthus amarus and Phyllanthus maderaspatensis in duck hepatitis B virus carrier Pekin ducks.
    Munshi A; Mehrotra R; Ramesh R; Panda SK
    J Med Virol; 1993 Dec; 41(4):275-81. PubMed ID: 8106861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2',3'-dideoxy-beta-L-5-fluorocytidine inhibits duck hepatitis B virus reverse transcription and suppresses viral DNA synthesis in hepatocytes, both in vitro and in vivo.
    Zoulim F; Dannaoui E; Borel C; Hantz O; Lin TS; Liu SH; Trépo C; Cheng YC
    Antimicrob Agents Chemother; 1996 Feb; 40(2):448-53. PubMed ID: 8834896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory effect of 2'-fluoro-5-methyl-beta-L-arabinofuranosyl-uracil on duck hepatitis B virus replication.
    Aguesse-Germon S; Liu SH; Chevallier M; Pichoud C; Jamard C; Borel C; Chu CK; Trépo C; Cheng YC; Zoulim F
    Antimicrob Agents Chemother; 1998 Feb; 42(2):369-76. PubMed ID: 9527788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biodistribution, stability, and antiviral efficacy of liposome-entrapped phosphorothioate antisense oligodeoxynucleotides in ducks for the treatment of chronic duck hepatitis B virus infection.
    Soni PN; Brown D; Saffie R; Savage K; Moore D; Gregoriadis G; Dusheiko GM
    Hepatology; 1998 Nov; 28(5):1402-10. PubMed ID: 9794928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.